This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Surgery, Other  • Oncology, Other  • Magnetic Resonance Imaging  • Alert me on articles by topic

Arch Surg. 2007;142(6):570.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Answer: Adrenocortical Carcinoma

Adrenocortical carcinoma is an uncommon cancer affecting 1 to 2 persons per 1 million persons.¹ It has been reported to have a bimodal age of distribution with the first peak occurring in the first decade of life and the second peak occurring between the fourth and fifth decades of life. These tumors are also more prevalent in women (58.6%) than men (41.1%).^2-3 Although adrenal carcinoma is potentially curable at early stages, only 30% of these malignancies are confined to the adrenal gland at the time of diagnosis.¹ For patients with localized malignancies, radical surgical excision is the treatment of choice and to date remains one of the only methods by which long-term disease-free survival may be achieved. Overall 5-year survival for tumors resected for cure is approximately 40%.

There are 2 important prognostic factors dictating long-term survival in patients with adrenocortical carcinoma: (1) completeness of resection, and (2) stage of . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Image of the Month—Quiz Case
Stacey D. Moore-Olufemi, Angela Cheng, and Gary A. Vercruysse
Arch Surg. 2007;142(6):569.
EXTRACT | FULL TEXT